FDA approval sees Orthocell's Remplir enter multi-billion dollar US nerve market

By Proactive Investors / April 07, 2025 / www.youtube.com / Article Link


Orthocell Ltd chairman John van der Wielen talked with Proactive about the company receiving FDA clearance for its nerve repair ...

Recent News

Base metals outperform over past month

April 06, 2026 / www.canadianminingreport.com

Gold stocks rise for second week

April 06, 2026 / www.canadianminingreport.com

Gold stocks rebound as metal declines

March 30, 2026 / www.canadianminingreport.com

Energy outperforms gold and tech for first time in years

March 23, 2026 / www.canadianminingreport.com
See all >
Share to Youtube Share to Facebook Facebook Share to Linkedin Share to Twitter Twitter Share to Tiktok